Recall D-0120-2026

US Class II Ongoing · initiated 2025-10-15

Recalling firm

ProRx LLC, PA

Product

Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03

Reason for recall

Lack of Assurance of Sterility

← All recalls